Antibiotice Ia
Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparat… Read more
Antibiotice Ia (ATB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.079x
Based on the latest financial reports, Antibiotice Ia (ATB) has a cash flow conversion efficiency ratio of 0.079x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RON73.24 Million) by net assets (RON922.94 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Antibiotice Ia - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Antibiotice Ia's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Antibiotice Ia Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Antibiotice Ia ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DIO Corporation
KQ:039840
|
0.015x |
|
Tuan Sing Holdings Limited
STU:TUS
|
0.020x |
|
Power Engineering Consulting JSC 2
VN:TV2
|
N/A |
|
CROSSJECT SA EO -10
F:74C
|
N/A |
|
Elentec Co. Ltd
KQ:054210
|
0.042x |
|
Highlight Tech
TWO:6208
|
-0.033x |
|
Indonesian Paradise Property
JK:INPP
|
-0.013x |
|
Plby Group Inc
NASDAQ:PLBY
|
2.841x |
Annual Cash Flow Conversion Efficiency for Antibiotice Ia (2022–2024)
The table below shows the annual cash flow conversion efficiency of Antibiotice Ia from 2022 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | RON894.31 Million | RON95.15 Million | 0.106x | -26.42% |
| 2023-09-30 | RON846.96 Million | RON122.46 Million | 0.145x | -19.82% |
| 2022-09-30 | RON641.43 Million | RON115.66 Million | 0.180x | -- |